These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27405864)

  • 1. Ivabradine: A Review of Labeled and Off-Label Uses.
    Oliphant CS; Owens RE; Bolorunduro OB; Jha SK
    Am J Cardiovasc Drugs; 2016 Oct; 16(5):337-47. PubMed ID: 27405864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular Disease.
    Nawarskas JJ; Bowman BN; Anderson JR
    Cardiol Rev; 2015; 23(4):201-11. PubMed ID: 25839989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate sinus tachycardia: focus on ivabradine.
    Abed HS; Fulcher JR; Kilborn MJ; Keech AC
    Intern Med J; 2016 Aug; 46(8):875-83. PubMed ID: 27059112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease.
    Weeda ER; Nguyen E; White CM
    Ann Pharmacother; 2016 Jun; 50(6):475-85. PubMed ID: 26917820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine in patients with inappropriate sinus tachycardia.
    Zellerhoff S; Hinterseer M; Felix Krull B; Schulze-Bahr E; Fabritz L; Breithardt G; Kirchhof P; Kääb S
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):483-6. PubMed ID: 20859616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
    Dillinger JG; Maher V; Vitale C; Henry P; Logeart D; Manzo Silberman S; Allée G; Levy BI
    Hypertension; 2015 Dec; 66(6):1138-44. PubMed ID: 26418022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS; Le Heuzey JY
    Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ivabradine and heart rate lowering in chronic heart failure: guideline update.
    Chow SL; Page RL; Depre C
    Expert Rev Cardiovasc Ther; 2018 Jul; 16(7):515-526. PubMed ID: 29902387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
    Rosano GM; Vitale C; Volterrani M
    Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Use of Ivabradine.
    Koruth JS; Lala A; Pinney S; Reddy VY; Dukkipati SR
    J Am Coll Cardiol; 2017 Oct; 70(14):1777-1784. PubMed ID: 28958335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S; Timmis AD
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on: Ivabradine: A Review of Labeled and Off-Label Uses.
    Champion S
    Am J Cardiovasc Drugs; 2016 Dec; 16(6):473-474. PubMed ID: 27743223
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review.
    Petite SE; Bishop BM; Mauro VF
    Am J Ther; 2018; 25(2):e247-e266. PubMed ID: 26910057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
    Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction.
    Cammarano C; Silva M; Comee M; Donovan JL; Malloy MJ
    Clin Ther; 2016 Feb; 38(2):387-95. PubMed ID: 26839043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.